Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG

Published:2007-11 Issue:6 Volume:87 Page:474-480
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Borsuk Sibele,Mendum Tom A.,Fagundes Michel Quevedo,Michelon Marcelo,Cunha Cristina Wetzel,McFadden Johnjoe,Dellagostin Odir Antônio

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference27 articles.

1. New use of BCG for recombinant vaccines;Stover;Nature,1991

2. The BCG experience: implications for future vaccines against tuberculosis;Bloom,1994

3. Recombinant BCG expressing the Leishmania surface-antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice;Abdelhak;Microbiology,1995

4. Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus;Bastos;Vaccine,2004

5. Recombinant Mycobacterium bovis Bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies;Matsumoto;J Exp Med,1998

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives;Vaccines;2022-05-19

2. CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tuberculosis Vaccine Candidate;Frontiers in Immunology;2022-03-30

3. Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine Babesiosis;Vaccines;2022-01-14

4. The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview;Frontiers in Microbiology;2021-10-21

5. Thirty years of recombinant BCG: new trends for a centenary vaccine;Expert Review of Vaccines;2021-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3